Connor, Clark & Lunn Investment Management Ltd. Laboratory Corp Of America Holdings Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$197.69 - $227.29 $263,916 - $303,432	1,335 New	1,335 $303,000
Q1 2022 May 12, 2022	SELL	$259.82 - $298.18 $3.19 Million - $3.66 Million	-12,280 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$271.6 - $314.21 $810,997 - $938,231	-2,986 Reduced 19.56%	12,280 $3.86 Million
Q3 2021 Nov 12, 2021	BUY	$274.82 - $308.34 $4.2 Million - $4.71 Million	15,266 New	15,266 $4.3 Million
Q1 2021 May 13, 2021	SELL	$204.88 - $255.03 $1.24 Million - $1.54 Million	-6,044 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$186.91 - $214.42 $1.1 Million - $1.26 Million	-5,891 Reduced 49.36%	6,044 $1.23 Million
Q3 2020 Nov 12, 2020	SELL	$167.03 - $201.3 $5.81 Million - $7 Million	-34,792 Reduced 74.46%	11,935 $2.25 Million
Q2 2020 Aug 13, 2020	BUY	$113.31 - $182.44 $2.79 Million - $4.49 Million	24,602 Added 111.2%	46,727 $7.76 Million
Q1 2020 May 13, 2020	BUY	$104.32 - $195.28 $638,960 - $1.2 Million	6,125 Added 38.28%	22,125 $2.8 Million
Q4 2019 Feb 12, 2020	BUY	$163.48 - $173.61 $2.17 Million - $2.3 Million	13,275 Added 487.16%	16,000 $2.71 Million
Q3 2019 Nov 13, 2019	SELL	$159.77 - $178.1 $2.34 Million - $2.61 Million	-14,675 Reduced 84.34%	2,725 $458,000
Q2 2019 Aug 07, 2019	BUY	$144.16 - $172.9 $2.51 Million - $3.01 Million	17,400 New	17,400 $3.01 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account